QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=FDB427644414B04AA39E61D5A47DB8BD;jsessionid=DF0BE80AF895D67586D160C20EA44219;jsessionid=7060A3E3B5520395A790C3D99B68DE3F;jsessionid=C77DEB70D6D8741F2B706E35E06BA34E;jsessionid=D87754BC6A5C5F3B9BA0EA0146E49111;jsessionid=D4B279F9D6746867C5F412651AA6010E (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=FDB427644414B04AA39E61D5A47DB8BD;jsessionid=DF0BE80AF895D67586D160C20EA44219;jsessionid=7060A3E3B5520395A790C3D99B68DE3F;jsessionid=C77DEB70D6D8741F2B706E35E06BA34E;jsessionid=D87754BC6A5C5F3B9BA0EA0146E49111;jsessionid=D4B279F9D6746867C5F412651AA6010E